PROF vs TMO · rev $10.7M vs P/E 24, rev $44.56B
Profound Medical Corp (PROF) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
PROF currently screens at market cap $238.7M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the PROF and TMO stock pages for the full models.
Not investment advice.